Tag: Investor’s Corner

Silvercrest Announces 2014 Financial Results; Cash Flow From Operations of $13.8 Million ($0.12 Per Share); Adjusted Earnings of $5.2 Million ($0.04 per Share)

Scott Drever, Chief Executive Officer and Director, stated; “2014 was another challenging but successful year for SilverCrest, as we transitioned from an open pit heap leaching operation at Santa Elena to an underground mining and milling operation. By the start of the fourth quarter, we had successfully commissioned both the underground mine and the 3,000 tonnes per day mill and processing facilities. SilverCrest achieved 93%…

Excellon Reports 2014 Annual and Fourth Quarter Financial Results

“We had a good start to 2014, though water management slowed development into the Rodilla and 623 mantos later in the year,” stated Brendan Cahill, President and Chief Executive Officer. “Production results during the second half of the year were disappointing, with higher operational costs due to an increased focus on development. That said, improved water management is a clear path to improving production, profitability and cash flows from Platosa, even at current silver prices, and we are increasingly confident in our plan to solve Platosa’s water issues permanently.

Aura Minerals Announces Year End 2014 Financial and Operating Results

Jim Bannantine, the Company’s President and Chief Executive Officer stated “Despite a difficult time in the market, we have been able to finance Aura’s requirements twice during 2014 with the support of our lenders, pay down our third party debt requirements and exceed the top end of our production guidance at our gold mines in 2014.

Morro Bay Resources Ltd. Retains CHF Investor Relations

Morro Bay Resources Ltd., a gold and silver exploration company targeting historic mining districts in the prolific Durango Silver belt, today announced it has engaged CHF Investor Relations, a highly regarded Canadian investor relations firm headquartered in Toronto, as its IR partner.

OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources Ticker Symbol: U:OPK

OPKO Health, Inc. announced today that SciVac Ltd., an Israeli entity in which OPKO has a forty-five percent ownership interest, has entered into an agreement pursuant to which Levon Resources Ltd. will acquire 100% of the issued and outstanding ordinary shares of SciVac by way of a court-approved plan of arrangement. Upon closing, Levon intends to change its name to SciVac Inc. and the current officers and directors of SciVac will be the officers and directors of New SciVac post-closing. The current owners of SciVac will own 68.4% of the outstanding shares of New SciVac post-closing, with OPKO owning approximately 30% of the outstanding shares.

Big North Announces Private Placement to Existing Shareholders and Other Investors is Still in Effect

BIG NORTH GRAPHITE CORP. announces, further to its news release issued on January 29, 2015, that the Company is proceeding with the non-brokered private placement of common shares of the Company at a price of $0.02 per Share pursuant to a discretionary waiver of the $0.05 minimum pricing requirement granted by the TSX Venture Exchange. The Company expects to close the Offering by April 3, 2015.

El Tigre Silver Announces Resignation of Board Member

El Tigre Silver Corp. reports that Mr. John Bluher has resigned as a Director of the Company because of obligations arising from his position at Northsight Capital, Inc. El Tigre thanks Mr. Bluher for his contributions to the Company and wishes him well in his future business endeavours.

Levon Resources Ltd. Announces Definitive Agreement To Acquire SciVac Ltd.

“I am excited to announce this transaction with SciVac, as I believe it will generate tremendous value for Levon shareholders,” stated Ron Tremblay, President and Chief Executive Officer of Levon. “In a difficult market for resource issuers, we have chosen to preserve capital while seeking to identify alternatives to create shareholder value. The acquisition of SciVac gives Levon ownership of Sci-B-Vac(tm), a commercial stage, potentially best in class hepatitis B vaccine…

All News